The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

July 6, 2021 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“I would say a minority of my patients are vaccine hesitant. When I explain that it is not a live vaccine, and that it would be worse for them if they got COVID, that helps them.”

You Might Also Like
  • Researchers Explore Response to COVID-19 Vaccines in the Elderly
  • More Info on the J&J COVID-19 Vaccine Thrombosis Scare
  • How Immunosuppression May Affect COVID-19 Vaccine Response
Explore This Issue
August 2021
Also By This Author
  • Patients Need Psychosocial Support Now More Than Ever: Q&A with Adena Batterman, MSW, LCSW

Dr. Stromquist says most of his patients are well informed about the vaccines due to extensive news coverage of their development and clinical trial results in the past year, but some share concerns with him based on media reports regarding thrombosis risk with certain vaccines or genetically altered components of some vaccines.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In St. Louis, Alfred Kim, MD, PhD, Washington University School of Medicine Division of Rheumatology, also encounters vaccine hesitancy among some patients. He says patients most commonly express concerns about the “risk of flares, side effects and the lack of long-term safety data. They’ll say, ‘I probably won’t mount a response, so why get it?’ Or they’ll express a lack of readiness, commenting, ‘You got it because your health is stable, but mine is not. I do not want to rock the boat.’ Misinformation, such as government tracking, or belief that the virus and COVID-19 aren’t real, are infrequent reasons.”

Dr. Navarro-Millan

Long COVID & Hesitancy

At her clinic at the Hospital for Special Surgery, New York City, Iris Navarro-Millan, MD, says most of her patients with rheumatic diseases have been eager to be vaccinated, because they were afraid of severe illness or death from COVID in an area especially hard-hit early in the pandemic.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

She sees more vaccine hesitancy among new patients with lingering COVID-19 symptoms that mimic post-infectious rheumatic disease. While these “COVID long-hauler” patients don’t have autoimmunity, they are referred to her practice because, as a rheumatologist, she is familiar with some of their presenting symptoms, which often resemble those seen in post-infectious arthritis or rheumatic fever, such as glomerulonephritis, hematologic and neurological manifestations, as well as cognitive symptoms (e.g., lack of concentration) or chronic fatigue.

“We are finding that getting a COVID vaccine improves long-COVID symptoms,” Dr. Navarro-Millan says. However, she continues, “I have seen five patients like this who do not want to get a vaccine. They can’t really articulate why. It’s just, ‘I don’t know.’ I probe them to find out why. One person had COVID twice and is still having chronic fatigue symptoms, but still doesn’t want to get the vaccine. She says she has to think about it. She couldn’t put in words why she doesn’t want to get the vaccine, except to say, ‘It’s my right to choose.’ It’s the same with the others.”

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions Tagged With: COVID-19, vaccination, vaccine, vaccine hesitancyIssue: August 2021

You Might Also Like:
  • Researchers Explore Response to COVID-19 Vaccines in the Elderly
  • More Info on the J&J COVID-19 Vaccine Thrombosis Scare
  • How Immunosuppression May Affect COVID-19 Vaccine Response
  • COVID-19 Vaccination Strategies Suggested for Patients on Anti-Rheumatic Immunosuppressive Therapy

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)